Back

VanEck Pharmaceutical ETF

Ticker: PPH ISIN: US92189F6925
Add to portfolio Portfolio analysis in 2min
ETF Concentrated top holdings
Morningstar
★★★★
TER
0.36%
Fund size
$1.18B
Holdings
25
Top 10
74.6%
Issuer
VanEck
$116.48 -0.13%
Price as of 2026-08-24 · NASDAQ

Performance by timeframe

Rolling returns
1 Month +4.64%
6 Months +6.59%
1 Year +35.36%
5 Years +11.12% p.a.+69.37%
10 Years +9.02% p.a.+137.12%
Since inception +6.78% p.a.+414.96%
Calendar year returns
YTD +14.48%
2025 +22.00%
2024 +8.06%
2023 +6.96%
2022 +2.64%
2021 +17.79%

Key stats

AUM
1.18B
Expense ratio
0.36%
Holdings
25
1Y return
35.36%
Volatility (1Y)
18.25%
52-week range
76.80 - 103.56
Section 1

Fund overview

Fund profile data from fundamentals.

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Category Health
Issuer VanEck
Domicile USA
Section 2

Exposure breakdown

Exposure breakdown shows how the fund is allocated across assets, sectors, regions, and size buckets.

Asset allocation

Stock US
63.58%
Stock non-US
36.37%
Cash
0.05%

Sectors

Healthcare
100.00%

Regions

North America
63.74%
Europe Developed
19.49%
United Kingdom
12.08%
Africa/Middle East
2.38%
Japan
2.31%

Market cap mix

Mega
59.55%
Big
30.90%
Medium
6.80%
Small
2.51%
Micro
0.19%
Section 3

Top holdings

Concentrated top holdings

Top holdings show which underlying securities drive the fund most.

Eli Lilly and Company
23.72%
Novartis AG ADR
9.04%
Merck & Company Inc
7.90%
Novo Nordisk A/S
6.31%
GlaxoSmithKline PLC ADR
4.82%
Johnson & Johnson
4.77%
Pfizer Inc
4.66%
McKesson Corporation
4.61%
AstraZeneca PLC ADR
4.46%
Bristol-Myers Squibb Company
4.33%
Section 4

Performance & risk

Historical return and risk indicators over fixed windows.

Returns

YTD return 18.81%
1M return 4.64%
6M return 6.59%
1Y return 35.36%
3Y return 11.13%
5Y return 69.37%
10Y return 6.71%

Risk

Volatility (1Y) 18.25%
Volatility (3Y) 13.35%
Sharpe ratio (3Y) 0.56
Beta 0.48
52-week range 76.80 - 103.56
Section 5

Portfolio characteristics

Fund concentration and composition metrics from source fields.

Overview

Holdings count 25
Top 10 weight 74.61%
Expense ratio 0.36%
Fund size 1.18B
Turnover 22.00%
Avg. market cap 220.01K

Details

Instrument metadata and source update timestamps.

Symbol PPH
Name VanEck Pharmaceutical ETF
Asset type ETF
Exchange NASDAQ
Currency USD
ISIN US92189F6925
Country USA
Code + exchange PPH.NASDAQ
Last price date 2025-12-15
Fundamentals updated 2025-12-16

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.